1. Home
  2. VCYT vs SAM Comparison

VCYT vs SAM Comparison

Compare VCYT & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • SAM
  • Stock Information
  • Founded
  • VCYT 2006
  • SAM 1984
  • Country
  • VCYT United States
  • SAM United States
  • Employees
  • VCYT N/A
  • SAM N/A
  • Industry
  • VCYT Medical Specialities
  • SAM Beverages (Production/Distribution)
  • Sector
  • VCYT Health Care
  • SAM Consumer Staples
  • Exchange
  • VCYT Nasdaq
  • SAM Nasdaq
  • Market Cap
  • VCYT 3.2B
  • SAM 3.5B
  • IPO Year
  • VCYT 2013
  • SAM 1995
  • Fundamental
  • Price
  • VCYT $40.58
  • SAM $251.86
  • Analyst Decision
  • VCYT Buy
  • SAM Hold
  • Analyst Count
  • VCYT 7
  • SAM 10
  • Target Price
  • VCYT $39.86
  • SAM $307.22
  • AVG Volume (30 Days)
  • VCYT 807.5K
  • SAM 158.0K
  • Earning Date
  • VCYT 02-20-2025
  • SAM 02-25-2025
  • Dividend Yield
  • VCYT N/A
  • SAM N/A
  • EPS Growth
  • VCYT N/A
  • SAM N/A
  • EPS
  • VCYT N/A
  • SAM 6.70
  • Revenue
  • VCYT $425,331,000.00
  • SAM $2,004,349,000.00
  • Revenue This Year
  • VCYT $25.25
  • SAM $0.72
  • Revenue Next Year
  • VCYT $10.05
  • SAM $2.42
  • P/E Ratio
  • VCYT N/A
  • SAM $37.65
  • Revenue Growth
  • VCYT 23.95
  • SAM N/A
  • 52 Week Low
  • VCYT $18.61
  • SAM $249.21
  • 52 Week High
  • VCYT $46.00
  • SAM $371.65
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 47.05
  • SAM 22.78
  • Support Level
  • VCYT $40.29
  • SAM $253.13
  • Resistance Level
  • VCYT $43.53
  • SAM $265.28
  • Average True Range (ATR)
  • VCYT 1.83
  • SAM 8.16
  • MACD
  • VCYT -0.17
  • SAM -3.98
  • Stochastic Oscillator
  • VCYT 30.12
  • SAM 4.73

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

About SAM Boston Beer Company Inc. (The)

Boston Beer is a top player in high-end malt beverages and adjacent categories in the us, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates over 95% of sales in the us.

Share on Social Networks: